Forbes August 25, 2024
Ozempic, the highly popular GLP-1 agonist drug touted by many celebrities for weight loss, is in short supply, according to its drug maker Novo Nordisk. The drug is FDA approved to treat diabetes but is often used off-label for its many other benefits which include weight loss. Semaglutide, the active ingredient in Ozempic, works by delaying emptying of the stomach keeping patients more full as well as working on hunger centers in the brain preventing cravings. It can also treat diabetes because it stimulates the pancreas to release insulin which then decreases blood sugar levels.
The drug is extremely effective for both diabetes and weight loss and has many additional benefits, including decreasing the risk of heart attack, stroke and...
Today's Sponsors
Today's Sponsor